跳至主要内容
临床试验/ACTRN12622000846729
ACTRN12622000846729招募中未知

A randomised controlled m-health trial evaluating the effect of gamification on physical activity, sleep quantity, and quality of life in young adults

niversity of Seville0 个研究点目标入组 100 人开始时间: 2022年6月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • To take part in the study, participants have to live in Seville (Spain), be 18–55 years of age and have access to an iOS or Android smartphone or tablet with internet access. Participants were recruited across the campus of the University of Seville, through social media and word of mouth.

排除标准

  • Participants will be excluded if they had a diagnosis of a sleep disorder such as insomnia, obstructive sleep apnoea or narcolepsy, if they were taking any sleep-aid medication or having any condition which would contraindicate participation in physical activity.

研究者

发起方
niversity of Seville

相似试验

已完成
3 期
A randomised, controlled clinical trial assessing the efficacy of;Lanreotide to halt disease progression in ADPKDpolycystic kidney disease100383601001965410029149Autosomal Dominant Polycystic Kidney Disease
NL-OMON39497niversitair Medisch Centrum Groningen300
进行中(未招募)
不适用
To investigate the effect of Lanreotide on renal function decline in ADPKD patientsFirst, to demonstrate whether Lanreotide attenuates progression of the renal phenotype in ADPKD patients as measuredby change in rate of renal function decline and change in renal volume. Second, to demonstrate whether Lanreotidemodifies progression of the liver phenotype in the subset of ADPKD patients with moderate to severe polycystic liverdisease as measured by change in liver volume.MedDRA version: 14.1Level: LLTClassification code 10023433Term: Kidney polycysticSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2011-005017-37-NLDIPAK Consortium
终止
不适用
:DECIDE Study: Utilising technology for Diet & Exercise Change In complex chronic conditions across Diverse EnvironmentsCardiometabolic HealthSolid Organ Transplant RecipientsChronic Kidney DiseaseMetabolic SyndromeDiet and Nutrition - ObesityCardiovascular - Other cardiovascular diseasesPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationMetabolic and Endocrine - Other metabolic disorders
ACTRN12620001282976Princess Alexandra Hospital67
尚未招募
Unknown
A clinical trial to study the effects of two procedures, shatpushpa siddha taila nasya and shatpushpa siddha taila matrabasti in patients with irregular menses and pcos.
CTRI/2024/03/063784Chaitalee Rajendra Jain
终止
3 期
Varenicline alone or with nicotine e-cigarettes for smoking cessation in people with mental illness and drug and/or alcohol dependence.SmokingMental illnessDrug and alcohol dependenceMental Health - AddictionMental Health - Other mental health disorders
ACTRN12616001355460The University of Auckland15